Molecular breast imaging for breast biopsy guidance

This study uses molecular breast imaging (MBI) to help guide biopsies for women with breast abnormalities. It has two parts: one for women with past MBI findings that turned out to be benign, and another for women who need a biopsy now based on recent imaging.

This trial tests whether a type of MRI called Diffusion Weighted Imaging (DWI) can more accurately identify breast issues in women with dense breast tissue. If you have dense breasts and have already had a breast MRI with DWI, this study may help improve future diagnosis.

This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.

This study is testing whether adding an MRI to your regular mammogram can help find any new breast cancers earlier. It is for women who have had breast cancer before and still have dense breast tissue, making mammograms harder to read.

This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.

This study looks at breast cancer risk by analyzing what is seen in dense breast tissue during a screening ultrasound. It may help improve how doctors evaluate risk in people with very dense breasts.